Conatus Pharmaceuticals (Nasdaq: CNAT) today announced that data from the Phase 1 clinical trial of emricasan, a first-in class, orally active caspase protease inhibitor designed to reduce the activity of enzymes that mediate inflammation and cell death, are being presented at The Liver Meeting®, the 64th Annual Meeting of the American Association fo

Gilead Sciences (NASDAQ: GILD) today announced results from a Phase
3 study, PHOTON-1, evaluating the investigational once-daily nucleotide
analogue sofosbuvir for the treatment of chronic hepatitis C virus (HCV)
infection among patients co-infected with HIV.

Gilead Sciences (NASDAQ: GILD) today announced results from two
Phase 2 studies evaluating an all-oral treatment regimen of the
investigational once-daily nucleotide analogue sofosbuvir plus ribavirin
(RBV) for both the prevention and treatment of recurrent chronic

Achillion Pharmaceuticals (NASDAQ: ACHN) today announced a poster presentation detailing the preclinical profile of ACH-3422, a uridine-analog nucleotide prodrug being advanced for the potential treatment of chronic hepatitis C viral infection (HCV).

Alnylam
Pharmaceuticals (NASDAQ: ALNY) announced today that it has presented new pre-clinical data
with ALN-AAT, an RNAi therapeutic targeting alpha-1 antitrypsin (AAT) in
…
Alnylam
Pharmaceuticals (NASDAQ: ALNY announced today that it has presented new pre-clinical data

Tesla Motors (NASDAQ: TSLA), which is run and was co-founded by billionaire Elon Musk, is scheduled to report its third-quarter 2013 results Tuesday, November 5, after the markets close.

Among other things, investors will have an eye on the gross profit margin.

This weekend in Barron's online: recommendations for investing in Latin America, as well as the prospects for Twitter, Discover, Boeing and Covanta.

Cover Story

"The New Latin America" by Reshma Kapadia.

After more than a decade of solid returns, Latin American stocks

One media outlet ran a headline (that it later changed) that read, "mystery solved."

That's might be a bit premature, but it is safe to say that the details behind that mystery barge moored in San Francisco Bay is almost certainly a Google (NASDAQ: GOOG) project.

The final week of October (and first day of November) proved to be moderately eventful.

From the launch of the iPad Air to rumors of solar-powered Apple (NASDAQ: AAPL) products, there were a number of intriguing moments.

Twitter's IPO received a lot of attention -- and a little criticism.

Amazon (NASDAQ: